Kyowa Hakko Europe
Trending Articles
Related Content
Dietary supplements
Kyowa Hakko Bio celebrates opening of expanded Cognizin citicoline manufacturing facility in Hofu, Japan
Kyowa Hakko Bio and Kyowa Hakko USA, Inc., a subsidiary of Kirin Holdings, is thrilled to announce the grand opening of its expanded citicoline manufacturing facilities at the Kyowa Hakko Bio Yamaguchi Production Center
Ingredients
Kyowa Hakko Bio’s 6’-sialyllactose sodium salt receives novel food approval in the EU
Kyowa Hakko Bio, a subsidiary of Kirin Holdings Company, is pleased to announce that its 6’-sialyllactose sodium salt (6’-SL), a human milk oligosaccharide (HMO), has been approved as a novel food by the European Commission in the European Union